Market Overview
The global placenta market was valued at USD 72.6 million in 2024 and is projected to reach USD 125 million by 2031, exhibiting a CAGR of 8.3% during the forecast period. This growth is primarily driven by increasing applications in cosmetic formulations and regenerative medicine, where placental extracts are valued for their high concentrations of growth factors, cytokines, and extracellular matrix components.
The market is concentrated in specific regions, with Japan accounting for the largest consumption share at approximately 36%, followed by Europe with 15% market share. North America and other Asian markets are also significant contributors. The market remains highly fragmented with the top three vendors holding about 30% market share combined.
USD 72.6 million in 2024
2032 USD 125 million by 2031
of 8.3%
Human Placental Extracts
Animal-Derived Placental Products
Human Placental Extracts dominate the market due to higher bioavailability and compatibility with human biology, though ethical sourcing remains a critical consideration for manufacturers in this space.
By Application
Cosmetics and Skincare
Regenerative Medicine
Nutraceuticals and Supplements
Research and Development
Cosmetics and Skincare
https://www.24lifesciences.com
Our Key Players
Merck KGaA (Germany)
Thermo Fisher Scientific Inc. (US)
Fujifilm Holdings Corporation (Japan)
ReGen Labs (US)
Pluristem Therapeutics Inc. (Israel)
